Phase
Condition
Bowel Dysfunction
Heartburn (Pediatric)
Stomach Discomfort
Treatment
Palmitoylethanolamide
Clinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with functional dyspepsia as diagnosed by the Rome IV criteria.
Subjects must provide witnessed written informed consent prior to any studyprocedures being performed.
Subjects aged 18-70 years old.
Male or female subjects.
Subjects who are capable to understand the study and the questionnaires, and tocomply with the study requirements.
Women of child-bearing potential agree to apply a highly effective method of birthcontrol during the entire duration of the trial. Highly effective birth control isdefined as those which result in a low failure rate (i.e., less than 1% per year)when used constantly and correctly such as implants, injectables, combined oralcontraceptive method, or some intrauterine devices (IUDs), sexual abstinence, orvasectomized partner. Women of non-childbearing potential may be included ifsurgically sterile (tubal ligation or hysterectomy) or postmenopausal with at least 2 year without spontaneous menses.
Exclusion
Exclusion Criteria:
Presence of a history of gastrointestinal surgery other than appendectomy andcholecystectomy.
Organic gastro-intestinal disease
Major psychiatric disorder such as major depression
Presence of coeliac disease, lupus, scleroderma and other systemic auto-immunedisease.
Patients with eosinophilic esophagitis
Presence of diabetes mellitus
Active H. Pylori infection or < 6 months after eradication
Predominant IBS (based on the Rome IV questionnaire)
Predominant GERD (based on the Rome IV questionnaire)
Patients taking prohibited medication
Females who are pregnant or lactating
Patients not capable to understand or be compliant with the study.
Study Design
Connect with a study center
KU Leuven
Leuven, Vlaams-Brabant 3000
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.